Invitation to Nanoform’s Q2 2023 Interim Report
Press release Nanoform Finland Plc August 10, 2023 11:00 a.m.…
Nanoform and Celanese Demonstrate Enhanced Drug Delivery through the Power of Smaller Implants
Press release Nanoform Finland Plc June 15, 2023 08:10 a.m.…
Invitation to Nanoform’s Q1 2023 Interim Report
Press release Nanoform Finland Plc May 11th, 2023 11:00 a.m.…
FIMEA renews Nanoform’s GMP license and Nanoform starts clinical API manufacturing of a blockbuster medicine candidate
Press release Nanoform Finland Plc May 9, 2023 15.00 Finnish…
Invitation to Nanoform Q4 and FY2022 report
Press release Nanoform Finland Plc February 14th, 2023 11:00 a.m.…
Invitation to Nanoform’s Interim Report January-September 2022
Press release Nanoform Finland Plc November 15, 2022 11:00 a.m.…
TargTex to present Tumour Eradication in Rodents from its Nanoformed Glioblastoma drug
Press release Nanoform Finland Plc October 17, 2022 08:10 a.m.…
Invitation to Nanoform’s Interim Report January-June 2022
Press release Nanoform Finland Plc August 10th, 2022 11:00 a.m.…